Dr. Matthew Schoenfeld, MD

Dr. Schoenfeld practices at Cardiovascular Associates of the Delaware Valley,P A in Toms River, New Jersey.

Dr. Schoenfeld's NPI, 1699031773, was assigned on April 3, 2012. Dr. Schoenfeld graduated from New York Medical College in 2012. Dr. Schoenfeld holds New Jersey license 25MA10525100.

Dr. Schoenfeld's primary practice is Cardiovascular Associates of the Delaware Valley,P A, at 9 Mule Rd, Toms River, NJ 08755 in Ocean County. The practice phone is (856) 547-0539.

Dr. Schoenfeld's primary practice is Cardiovascular Associates of the Delaware Valley,P A in Toms River, New Jersey. Dr. Schoenfeld is also affiliated with Jersey Shore University Medical Center. The medical group on file is Cardiovascular Associates of The Delaware Valley (The Heart House). Dmand AI also links Dr. Schoenfeld to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schoenfeld practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Schoenfeld's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Schoenfeld is licensed in New Jersey.

CMS data shows 4,412 Medicare services from Dr. Schoenfeld across 53 procedure codes in 2024, for 781 Medicare patients. Medicare paid $474,036 for them.

CMS counts 781 Medicare patients who saw Dr. Schoenfeld in 2024. The largest group is 65 to 74, with 312 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schoenfeld's median patient age at 70, with 41% women.

In 2024, Dr. Schoenfeld wrote 4,810 Medicare Part D claims for 673 patients. 81% of them were for generic drugs. CMS names the drug for 4,482 of them, across 63 drugs with 11 or more claims each, at $1,044,384 in total drug cost. In 2023, CMS named 4,034 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Schoenfeld for performance year 2024, reported as part of a group. Dr. Schoenfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 136 procedures of coronary angioplasty and stenting by Dr. Schoenfeld, more than 98% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,013 general payments to Dr. Schoenfeld from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Abbott Laboratories paid the most, $13,389.

Dr. Schoenfeld graduated from New York Medical College in 2012.